Eiko LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 117.27 million compared to INR 201.2 million a year ago. Revenue was INR 123.74 million compared to INR 205.88 million a year ago. Net income was INR 4.86 million compared to INR 5.59 million a year ago. Basic earnings per share from continuing operations was INR 0.58 compared to INR 0.73 a year ago. Diluted earnings per share from continuing operations was INR 0.58 compared to INR 0.73 a year ago.